Global Ovarian Cancer Market Holds High Demand for Maintenance Therapies as Relapse Cases Remain Above Acceptable Levels
Though ovarian cancer ranks seventh in the list of the most common types of cancers worldwide, its affliction rate continues to rise. These are the estimates of the World Cancer Research Fund International, which also states that the prevalence of this disease remarkably higher in less developed countries. The Asia Pacific market has not only seen a rise in the number of ovarian cancer cases reported annually, but has also been a fertile playground for several new therapies to be developed. Browse the full Asia Pacific Ovarian Cancer Market Report Within Asia Pacific, countries where ovarian cancer pipelines are most active are: China, India, Japan and Australia. Even as this market continues to thrive and grow at a steady pace, a recent market report by GBI research carries some interesting trends. These are: · The Asia Pacific ovarian cancer therapies market features a white space for maintenance therapies. At present, the most widely used type of chemotherapy is the platinum-based ...